Dongsung to release buccal insulin product in 2011

Published: 2009-09-23 06:56:00
Updated: 2009-09-23 06:56:00
Dongsung Pharm plan to introduce oral insulin (Oral-lyn) for the treatment of subjects with Type-1 and Type-2 diabetes in January 2011.

In August 2008, Dongsung obtained exclusive right to market Oral-lyn in Korea from the US Generex Biotechnology Corporation, the leader in drug delivery for m...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.